JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$5.47B |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.17B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$2.05B |
| 4 |
Amazon
AMZN
|
+$1.96B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$1.72B |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$1.31B |
| 3 |
UnitedHealth
UNH
|
+$1.26B |
| 4 |
Automatic Data Processing
ADP
|
+$1.17B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.08B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.28% |
| 2 | Technology | 17.17% |
| 3 | Healthcare | 10.79% |
| 4 | Financials | 9.36% |
| 5 | Consumer Discretionary | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
EPIX
4901
DELISTED
ESSA Pharma
EPIX
| $177K | ﹤0.01% |
59,706
+50,955
| +582% | +$150K |
2020 Q3
10 quarters
|
|
4902
Holley
HLLY
$280M
| $177K | ﹤0.01% |
64,634
+13,126
| +25% | +$33.5K |
2021 Q4
5 quarters
|
|
4903
Ring Energy
REI
$352M
| $177K | ﹤0.01% |
93,065
-17,668
| -16% | -$38.1K |
2017 Q2
23 quarters
|
|
|
FYBR
4904
PUT
DELISTED
Frontier Communications
FYBR
| $175K | ﹤0.01% |
+7,700
| New | +$206K |
2023 Q1
0 quarters
|
|
4905
Schwab 5-10 Year Corporate Bond ETF
SCHI
$10.8B
| $175K | ﹤0.01% |
+7,818
| New | +$172K |
2023 Q1
0 quarters
|
|
|
URG
4906
Ur-Energy
URG
$454M
| $175K | ﹤0.01% |
164,576
+42,489
| +35% | +$48K |
2021 Q2
7 quarters
|
|
4907
HireQuest
HQI
$269M
| $174K | ﹤0.01% |
8,040
+7,690
| +2,197% | +$163K |
2021 Q2
7 quarters
|
|
4908
PUT
American Electric Power
AEP
$65.7B
| $173K | ﹤0.01% |
1,900
-39,500
| -95% | -$3.61M |
2018 Q4
17 quarters
|
|
4909
Hooker Furnishings Corp
HOFT
$138M
| $173K | ﹤0.01% |
9,479
+9,441
| +24,845% | +$191K |
2016 Q3
26 quarters
|
|
4910
Tonix Pharmaceuticals
TNXP
$136M
| $173K | ﹤0.01% |
15
+13
| +650% | +$223K |
2021 Q2
7 quarters
|
|
4911
Distribution Solutions Group
DSGR
$1.62B
| $172K | ﹤0.01% |
7,600
+2,014
| +36% | +$42.3K |
2016 Q4
25 quarters
|
|
4912
Methanex
MEOH
$4.73B
| $172K | ﹤0.01% |
3,691
-6,550
| -64% | -$308K |
2015 Q2
31 quarters
|
|
4913
Mizuho Financial
MFG
$135B
| $171K | ﹤0.01% |
60,627
+10,034
| +20% | +$30.7K |
2013 Q2
39 quarters
|
|
|
AOD
4914
abrdn Total Dynamic Dividend Fund
AOD
$1.07B
| $171K | ﹤0.01% |
21,187
+7,961
| +60% | +$64.7K |
2022 Q4
1 quarter
|
|
4915
Aura Biosciences
AURA
$634M
| $171K | ﹤0.01% |
18,498
+7,752
| +72% | +$80.5K |
2021 Q4
5 quarters
|
|
|
SCPH
4916
DELISTED
scPharmaceuticals
SCPH
| $171K | ﹤0.01% |
18,844
-33,738
| -64% | -$247K |
2022 Q4
1 quarter
|
|
|
FIRY
4917
Firy Inc
FIRY
$210M
| $171K | ﹤0.01% |
14,437
-13,954
| -49% | -$185K |
2020 Q3
10 quarters
|
|
4918
Schwab Fundamental Emerging Markets Large Company Index ETF
FNDE
$10.5B
| $171K | ﹤0.01% |
6,559
+6,172
| +1,595% | +$161K |
2022 Q3
2 quarters
|
|
4919
State Street SPDR MSCI USA StrategicFactors ETF
QUS
$1.58B
| $171K | ﹤0.01% |
1,473
| – | – |
2022 Q4
1 quarter
|
|
|
RMT
4920
Royce Micro-Cap Trust
RMT
$739M
| $170K | ﹤0.01% |
19,396
+15,151
| +357% | +$139K |
2022 Q4
1 quarter
|
|
|
MAGN
4921
Magnera Corp
MAGN
$420M
| $170K | ﹤0.01% |
4,082
+395
| +11% | +$18.2K |
2013 Q2
39 quarters
|
|
4922
Cato Corp
CATO
$47.4M
| $169K | ﹤0.01% |
19,057
+1,645
| +9% | +$15.6K |
2013 Q2
39 quarters
|
|
|
VLD
4923
DELISTED
Velo3D, Inc.
VLD
| $169K | ﹤0.01% |
2,125
+437
| +26% | +$39.2K |
2021 Q3
6 quarters
|
|
4924
Alpha Tau Medical
DRTS
$1.36B
| $168K | ﹤0.01% |
58,577
-771
| -1% | -$2.69K |
2022 Q2
3 quarters
|
|
4925
Erasca
ERAS
$5.07B
| $168K | ﹤0.01% |
55,734
-87,156
| -61% | -$317K |
2021 Q3
6 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2023 Portfolio in Review
As of Q1 2023, JP Morgan Chase held 7,579 positions worth $821B, up 8.2% from $759B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q1 2023 filing shows 751 new, 3,314 increased, 2,056 reduced and 652 closed positions. Its largest new stake was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M. The largest sale was Eli Lilly, an estimated $1.72B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 27% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q1 2023 buy was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q1 2023, an estimated $5.47B increase.
- JP Morgan Chase's biggest Q1 2023 reduction was Eli Lilly, cutting an estimated $1.72B.
- JP Morgan Chase fully exited IAA, Inc. Common Stock in Q1 2023, selling an estimated $155M.
- JP Morgan Chase's ten largest holdings make up 17% of its $821B portfolio in Q1 2023.
- JP Morgan Chase opened 751 new positions and closed 652 in Q1 2023.
- JP Morgan Chase's portfolio value rose 8.2% quarter-over-quarter to $821B.
Based on JP Morgan Chase's 13F filing for Q1 2023, filed 11 May 2023.